SCHEMBL7307941

SCHEMBL7307941

COC(=O)C(C)c1c(O)nc(OC)c2cc(OC)c(OC)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MT-CO2 P00403 1/20 0.34
ALDH1A1 P00352 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
JAK2 O60674 2/20 0.32
JAK1 P23458 2/20 0.32
TYK2 P29597 2/20 0.32
JAK3 P52333 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
MAPT P10636 2/20 0.32
PDGFRA P16234 1/20 0.32
KDR P35968 1/20 0.32
LMNA P02545 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305960 0.86 KDM4E (0.38) PDE3BPDE3ASMN1; SMN2MT-CO2ALDH1A1
SCHEMBL7315403 0.76 SLC10A2 (0.37) MT-CO2ALDH1A1KDM4EGAAMAPT
SCHEMBL7317441 0.73 KDM4E (0.39) PDE3BPDE3ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL7307946 0.69 PDE3B (0.54) PDE3BPDE3AKDM4ETNF
SCHEMBL7312102 0.67 PDE3B (0.46) PDE3BPDE3ASMN1; SMN2ALDH1A1KDM4E
Fluoride SCHEMBL7318311 0.67 PDE3B (0.35) PDE3BPDE3ASMN1; SMN2MT-CO2
SCHEMBL8708452 0.65 MT-CO2 (0.36) SMN1; SMN2MT-CO2ALDH1A1HPGD
SCHEMBL490924 0.64 PKM (0.48) MT-CO2ALDH1A1CYP3A4CYP2C9KDM4E
SCHEMBL5022505 0.63 CYP2C19 (0.54) SMN1; SMN2MT-CO2ALDH1A1CYP2C9HPGD
SCHEMBL31083332 0.63 CYP2C19 (0.54) SMN1; SMN2MT-CO2ALDH1A1CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed